Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Cyclophosphamide × Dermatologic × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 167 Expanded_access 1

Sponsor

Cancer Type

Lymphoid 2 Other hematologic neoplasm 1 Dermatologic 1

Conditions

Interventions

trametinib 3 dabrafenib 3 talimogene laherparepvec 2 pembrolizumab 2 Nivolumab 2 Ipilimumab 2 ulixertinib 1 tebentafusp 1 pegilodecakin 1 omaveloxolone 1 methyl 5-aminolevulinate 1 efineptakin alfa 1 cemiplimab 1 balstilimab 1 avelumab 1 aldesleukin 1 Rose Bengal 1 Melphalan 1 HhAntag691 1 Cyclophosphamide 1 Brentuximab Vedotin 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01005537 2010-08-06

Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma

Fred Hutchinson Cancer Center

No longer available

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡